Table 4. Effect of L-arginine on fatty acid composition in longissimus muscle.
Fatty acid | Control | 1% arginine |
---|---|---|
C14:0 | 1.71 ± 0.19 | 1.65 ± 0.15 |
C15:0 | 0.03 ± 0.008 | 0.03± 0.008 |
C16:0 | 24.50 ± 0.90 | 23.12 ± 0.78 |
C16:1 | 4.25 ± 0.46 | 4.32 ± 0.71 |
C17:0 | 0.19 ± 0.04 | 0.17 ± 0.04 |
C17:1 | 0.25 ± 0.05 | 0.23 ± 0.04 |
C18:0 | 14.56 ± 0.49 | 15.46 ± 0.96 |
C19:0 | 0.06 ± 0.01 | 0.05 ± 0.01 |
C18:1 | 44.97 ± 0.78 | 44.64 ± 1.77 |
C18:2 | 7.08 ± 0.37 | 7.76 ± 0.11 |
C18:3 | 0.27 ± 0.04 | 0.31 ± 0.02 |
C20:0 | 0.24 ± 0.04 | 0.27 ± 0.04 |
C20:1 | 0.86 ± 0.08 | 1.11 ± 0.10** |
C20:2 | 0.36 ± 0.06 | 0.33 ± 0.03 |
C20:3 | 0.10 ± 0.02 | 0.09 ± 0.02 |
C20:4 | 0.40 ± 0.03 | 0.39± 0.05 |
C22:6 | 0.15 ± 0.06 | 0.39± 0.06* |
SFA | 41.23± 1.64 | 40.75 ± 1.98 |
MUFA | 50.33 ± 1.37 | 50.30 ± 2.62 |
PUFA | 8.36 ± 0.58 | 9.27 ± 0.30* |
Data are means of fatty acid percentages ± SEM, n = 24.
Within a row, means with * indicate a significant difference (P < 0.05), means with ** indicate a significant difference (P < 0.01).
SFA, saturated fatty acids; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids.